Novozymes A/S (OTCMKTS:NVZMY) Shares Gap Down – Here’s What Happened

Novozymes A/S (OTCMKTS:NVZMY)’s stock price gapped down prior to trading on Monday. The stock had previously closed at $71.80, but opened at $67.85. Novozymes A/S shares last traded at $67.8480, with a volume of 906 shares trading hands.

Novozymes A/S Stock Down 3.4%

The firm’s 50 day moving average is $67.32 and its two-hundred day moving average is $62.69. The firm has a market cap of $27.46 billion, a P/E ratio of 39.20, a price-to-earnings-growth ratio of 3.08 and a beta of 0.86. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 0.25.

Novozymes A/S (OTCMKTS:NVZMY) last issued its earnings results on Thursday, November 5th. The biotechnology company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.26). The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.28 billion. Novozymes A/S had a net margin of 15.59% and a return on equity of 6.56%. As a group, research analysts anticipate that Novozymes A/S will post 2.45 EPS for the current fiscal year.

Institutional Trading of Novozymes A/S

An institutional investor recently raised its stake in Novozymes A/S stock. Elefante Mark B boosted its holdings in shares of Novozymes A/S (OTCMKTS:NVZMY) by 73.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,900 shares of the biotechnology company’s stock after acquiring an additional 2,500 shares during the period. Elefante Mark B’s holdings in Novozymes A/S were worth $371,000 as of its most recent filing with the Securities and Exchange Commission. 0.03% of the stock is currently owned by hedge funds and other institutional investors.

Novozymes A/S Company Profile

Novozymes A/S was a Denmark-based biotechnology company that developed and produced enzymes and microorganisms for industrial and consumer applications. Its solutions were used in areas including household care, food and beverages, agriculture, animal health and bioenergy. The company’s products included enzymes used in detergents, baking, brewing and biofuel production, as well as microbial solutions for agricultural and other industrial processes. Novozymes served customers in markets around the world.